The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDEV.L Regulatory News (DEV)

  • There is currently no data for DEV

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Funding Facility

22 Aug 2022 07:15

RNS Number : 6908W
Dev Clever Holdings PLC
22 August 2022
 

22 August 2022

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ("MAR"). With the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

NOT FOR PUBLICATION OR RELEASE IN OR INTO THE UNITED STATES OR AUSTRALIA, CANADA, JAPAN, NEW ZEALAND, THE REPUBLIC OF IRELAND OR THE REPUBLIC OF SOUTH AFRICA, OR ANY PROVINCE OR TERRITORY THEREOF OR TO OR FOR THE ACCOUNT OF ANY NATIONAL, RESIDENT OR CITIZEN OF THE UNITED STATES OR ANY PERSON RESIDENT IN AUSTRALIA, CANADA, JAPAN, NEW ZEALAND, THE REPUBLIC OF IRELAND OR THE REPUBLIC OF SOUTH AFRICA.

Dev Clever Holdings plc

 

("Dev Clever" or the "Company")

 

USD$30 million funding facility

 

Dev Clever (LSE: DEV), a leading developer of mobile and immersive experiences, is pleased to announce that it has obtained an up to USD$30 million three-year unsecured funding facility (the "Facility") with RiverFort Global Opportunities PCC Limited ("RiverFort").

The Facility provides Dev Clever with a significantly strengthened balance sheet and enables it to pursue the global EdTech growth opportunity with sustained confidence.

Dev Clever's ability to draw down on the Facility is dependent on the satisfaction of the drawdown conditions, principally its re-admission to the standard segment of the Main Market of the London Stock Exchange ("Re-admission"). Upon Re-admission, an initial amount of USD$5 million will be available to be advanced to Dev Clever within 20 business days of Re-admission per the terms of the funding agreement (the "Initial Advance"). Dev Clever will then have access to further capital up to the total commitment amount as mutually agreed between the Company and RiverFort. The term of the Facility is for a period of 36 months from 20 August 2022.

Re-admission is contingent on the publication of a prospectus and FCA approval of eligibility. Work towards this continues to progress.

Chris Jeffries, CEO of Dev Clever, commented: "I am delighted to announce this facility with RiverFort that secures a funding pipeline which underpins the execution of our growth ambitions. It provides us with the balance sheet strength that enables us to continue delivering our growth strategy with confidence alongside our funding partners at RiverFort. We are committed to ensuring our shares are re-listed as soon as possible and are continuing to prioritise this. We look forward to updating the market on this in due course."

The key terms of the Facility are as follows:

· Commitment Amount: up to thirty million US dollars ($30,000,000).

· Term: the Facility is available for 36 months from 20 August 2022.

· Fees: an implementation fee equal to 1% of the Facility payable in cash on the earlier of six months from 20 August 2022 and 30 days after the re-admission of the Company to standard segment of the Main Market of the London Stock Exchange ("Re-admission").

· Initial Advance: an amount of five million US dollars ($5,000,000) to be advanced to the Company within 20 business days of Re-admission subject to drawdown conditions including, inter alia, Re-admission.

· Further Advances: RiverFort may, at its absolute discretion, advance further amounts to the Company during the Facility term subject to certain conditions including, inter alia, the delivery to RiverFort of a drawdown notice by the Company.

· Interest: interest applies on the outstanding balance at any time at a rate of 10% per annum.

· Repayment: the outstanding amount of each advance is repayable on the date falling 24 months after the advance was made and the Company can prepay the outstanding amount subject to relevant conditions, including, inter alia, the payment of a 5% redemption fee.

· Conversion: from the date commencing three months after Re-admission, RiverFort may elect, at its discretion, to convert the outstanding balance of the Facility into new ordinary shares in the Company. The conversion will be at the lower of:

i) a 30% premium to the average daily volume weighted average price ("VWAP") for the previous five days' trading prior to the drawdown of the relevant amount (the "Reference Price") being converted; and

ii) 92% of the average of the five lowest VWAPs in the 20 trading days prior the notice to convert being delivered by RiverFort to the Company.

· Warrants: RiverFort will receive warrants ("Warrants") with each advance of the Facility. Such number of Warrants to be calculated as 50% of each advance divided by the applicable Reference Price. The Warrants will have an exercise price equal to 130% of the applicable Reference Price. The Warrants will have an exercise period of 48 months from grant.

· Other terms: the Facility includes certain undertakings, warranties and indemnities from the Company in favour of RiverFort. Normal events of default provisions apply.

-ends-

 

For further information please contact:

 

Dev Clever Holdings plc

+44 (0) 1827 930 408

Christopher Jeffries

Joint Chief Executive Officer and Executive Chairman

Ankur Aggarwal

Joint Chief Executive Officer

Nicholas Ydlibi

Chief Financial Officer

Novum Securities Limited - Financial Adviser and Joint Broker

+44 (0) 20 7399 9400

David Coffman / Colin Rowbury

 

finnCap Limited - Joint Broker

+44 (0) 20 7220 0500

Jonny Franklin-Adams / Abigail Kelly / George Dollemore (Corporate Finance)

Richard Chambers / Harriet Ward (ECM)

Buchanan Communications

+44 (0) 207 466 5000

Chris Lane / Kim van Beeck / Toto Berger

 

Notes to Editors:

About Dev Clever

Dev Clever Holdings plc, together with its wholly owned subsidiaries, is a software and technology group based in Stafford, United Kingdom, and Noida, India, specialising in the use of lightweight integrations of cloud-based VR and gamification technologies to deliver rich customer engagement experiences across both the education and commercial sectors. In January 2019, Dev Clever listed on the Standard List of the London Stock Exchange. The Group's core focus is the development and commercialisation of its core Educate platforms.

Dev Clever aims to reduce the global skills shortage by delivering an enhanced careers guidance service via its online platforms, Launchmycareer.com and Launchyourcareer.com, and virtual reality software (Victar VR). The business has established a global partnership with Lenovo to roll out its service worldwide, with offerings already on the market in the UK, US, and Canada. Dev Clever is also focused on the Indian market and has partnered with its National Independent Schools Alliance (NISA) to provide a comprehensive service offering within Indian budget private schools. Through this, the business has been developing and has launched a direct-to-consumer offering in India.

 

For further information, please visit www.devcleverholdingsplc.com

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDFBLLLLVLBBBF
Date   Source Headline
21st Dec 20207:00 amRNSAgreement
18th Dec 20204:41 pmRNSSecond Price Monitoring Extn
18th Dec 20204:36 pmRNSPrice Monitoring Extension
7th Dec 202011:00 amRNSPrice Monitoring Extension
1st Dec 20207:00 amRNSUpdate on Subscription Agreement
13th Nov 20202:30 pmRNSHolding(s) in Company
6th Nov 20207:00 amRNSHeads of Terms
2nd Nov 20207:00 amRNSUpdate To Subscription Agreement
27th Oct 20202:15 pmRNSHolding(s) in Company
5th Oct 20204:40 pmRNSSecond Price Monitoring Extn
5th Oct 20204:35 pmRNSPrice Monitoring Extension
5th Oct 20207:00 amRNSTR1
5th Oct 20207:00 amRNSTotal Voting Rights
23rd Sep 20207:00 amRNSNew Appointment
17th Sep 20207:00 amRNSPartnership announcement
16th Sep 202010:10 amRNSHolding(s) in Company
15th Sep 20202:15 pmRNSHolding in Company
14th Sep 20207:00 amRNSExercise of warrants
11th Sep 202010:00 amRNSHolding(s) in Company
10th Sep 20207:00 amRNSTrading update and new contract
8th Sep 20204:37 pmRNSHolding(s) in Company
7th Sep 20207:00 amRNSIssue of Equity
3rd Sep 20207:00 amRNSIssue of Equity
1st Sep 20207:00 amRNSUpdate to Right to Subscribe
18th Aug 20203:45 pmRNSHolding(s) in Company
3rd Aug 20207:01 amRNSDirector/PDMR Shareholding
3rd Aug 20207:00 amRNSIssue of Equity
29th Jul 20207:00 amRNSIssue of equity and conversion of debt
27th Jul 20207:05 amRNSHalf-year Report
27th Jul 20207:00 amRNSUpdate to Right to Subscribe
17th Jul 202010:00 amRNSHolding(s) in Company
16th Jul 20209:31 amRNSHolding(s) in Company
15th Jul 20207:00 amRNSHolding(s) in Company
10th Jul 20203:00 pmRNSHolding(s) in Company
9th Jul 20207:00 amRNSProduct Launch
6th Jul 20207:00 amRNSCommercial agreement
8th Jun 20202:05 pmRNSHolding(s) in Company
3rd Jun 20207:00 amRNSVirtual Open Week
26th May 20207:00 amRNSDirectorate Change
22nd May 20207:00 amRNSExercise of employee share options
21st May 202010:30 amRNSDirector/PDMR Shareholding
14th May 20203:50 pmRNSDirector/PDMR Shareholding
13th May 202010:30 amRNSRight to Subscribe
13th May 202010:30 amRNSDirector/PDMR Shareholding
6th May 20207:00 amRNSProduct Launch
4th May 20209:00 amRNSPrice Monitoring Extension
30th Apr 20201:30 pmRNSHolding(s) in Company
29th Apr 20207:00 amRNSContract
20th Apr 20204:41 pmRNSSecond Price Monitoring Extn
20th Apr 20204:36 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.